Assadi Farahnak K
Section of Pediatric Nephrology, Rush Medical College, Rush Children's Hospital, Chicago, IL 60612, USA.
Pediatr Nephrol. 2002 Feb;17(2):107-10. doi: 10.1007/s00467-001-0762-5.
Microalbuminuria is a harbinger of progressive renal disease and cardiovascular complications in patients with diabetes mellitus. The method most commonly used to measure microalbuminuria relies on a timed urine collection, either a 24-h or overnight specimen, which is time-consuming, cumbersome, and often inaccurate. We compared microalbumin-creatinine ratio (U(MA)/U(Cr)) in a random urine sample obtained after the first voided morning specimen with the quantity of microalbumin in a 24-h collection to determine whether the U(MA)/U(Cr) correlates with the microalbumin content of 24-h urine collection. In a study of 124 urine samples from 97 pediatric patients with type I diabetes, daily microalbumin excretion varied from 7 to 108 mg/24-h with a mean of 55.7 +/- 18.2 mg and U(MA)/U(Cr) ranged from 5 to 59 microg/mg with a mean of 39.4 +/- 11.3. An excellent correlation was found between the microalbumin excretion measured in 24-h urine collections and the random urine U(MA)/U(Cr) specimens (r=0.89, P<0.001). All patients who excreted more than 30 mg microalbumin in the 24-h specimen also had a U(MA)/U(Cr) of more than 20 microg/mg in the randomly voided sample. Microalbuminuria was unlikely if the U(MA)/U(Cr) was below 20 microg/mg. The results of this study indicate that the measurement of U(MA)/U(Cr) in a second voided morning specimen is a simple and reliable method for monitoring microalbuminuria in diabetic patients and may replace the need to assess quantitative microalbumin excretion on 24-h urine collections.
微量白蛋白尿是糖尿病患者进行性肾脏疾病和心血管并发症的先兆。最常用于测量微量白蛋白尿的方法依赖于定时尿液收集,即24小时或过夜样本,这种方法既耗时又麻烦,而且往往不准确。我们将首次晨尿后随机尿液样本中的微量白蛋白-肌酐比值(U(MA)/U(Cr))与24小时收集尿液中的微量白蛋白量进行比较,以确定U(MA)/U(Cr)是否与24小时尿液收集的微量白蛋白含量相关。在一项对97名1型糖尿病儿科患者的124份尿液样本的研究中,每日微量白蛋白排泄量在7至108毫克/24小时之间,平均为55.7±18.2毫克,U(MA)/U(Cr)范围为5至59微克/毫克,平均为39.4±11.3。在24小时尿液收集测量的微量白蛋白排泄量与随机尿液U(MA)/U(Cr)样本之间发现了极好的相关性(r = 0.89,P<0.001)。所有在24小时样本中排泄超过30毫克微量白蛋白的患者,其随机排尿样本中的U(MA)/U(Cr)也超过20微克/毫克。如果U(MA)/U(Cr)低于20微克/毫克,则不太可能存在微量白蛋白尿。本研究结果表明,测量第二次晨尿样本中的U(MA)/U(Cr)是监测糖尿病患者微量白蛋白尿的一种简单可靠的方法,可能无需评估24小时尿液收集的微量白蛋白排泄量。